AHNAK2 and nonpapillary renal cell carcinoma: Thus, with the GSEA data regarding lipid synthesis and the TCA cycle pointing towards AHNAK2 exerting an oncogenic effect in ccRCC through enhancing lipid synthesis, affecting tumour metabolism, and promoting hypoxia-induced EMT, these mechanisms may also explain the reduced proliferation of cells with shRNA knockdown of AHNAK2.